User profiles for John A. Butman

John A. Butman

National Institutes of Health
Verified email at nih.gov
Cited by 20433

[HTML][HTML] Phase II trial of single-agent bevacizumab followed by bevacizumab plus irinotecan at tumor progression in recurrent glioblastoma

…, I Stroud, N Garren, M Mackey, JA Butman… - Journal of clinical …, 2009 - ncbi.nlm.nih.gov
Results Forty-eight heavily pretreated patients were accrued to this study. Thromboembolic
events (12.5%), hypertension (12.5%), hypophosphatemia (6%), and thrombocytopenia (6%) …

Magnetic resonance imaging and computed tomography in emergency assessment of patients with suspected acute stroke: a prospective comparison

…, CS Kidwell, LM Nentwich, M Luby, JA Butman… - The Lancet, 2007 - thelancet.com
Background Although the use of magnetic resonance imaging (MRI) for the diagnosis of
acute stroke is increasing, this method has not proved more effective than computed …

Comparison of MRI and CT for detection of acute intracerebral hemorrhage

…, S Starkman, MD Hill, AM Demchuk, JA Butman… - Jama, 2004 - jamanetwork.com
ContextNoncontrast computed tomography (CT) is the standard brain imaging study for the
initial evaluation of patients with acute stroke symptoms. Multimodal magnetic resonance …

[HTML][HTML] Neonatal-onset multisystem inflammatory disease responsive to interleukin-1β inhibition

…, SC Hoffmann, SM Holland, JA Butman… - … England Journal of …, 2006 - Mass Medical Soc
Background Neonatal-onset multisystem inflammatory disease is characterized by fever,
urticarial rash, aseptic meningitis, deforming arthropathy, hearing loss, and mental retardation. …

[HTML][HTML] An autoinflammatory disease with deficiency of the interleukin-1–receptor antagonist

…, DL Stone, ML Turner, S Hill, JA Butman… - … England Journal of …, 2009 - Mass Medical Soc
Background Autoinflammatory diseases manifest inflammation without evidence of infection,
high-titer autoantibodies, or autoreactive T cells. We report a disorder caused by mutations …

Neurofibromatosis type 2

AR Asthagiri, DM Parry, JA Butman, HJ Kim, ET Tsilou… - The Lancet, 2009 - thelancet.com
Neurofibromatosis type 2 is an autosomal-dominant multiple neoplasia syndrome that results
from mutations in the NF2 tumour suppressor gene located on chromosome 22q. It has a …

[PDF][PDF] Inhibition of B cell receptor signaling by ibrutinib in primary CNS lymphoma

…, M Roschewski, BC Widemann, JA Butman… - Cancer cell, 2017 - cell.com
Primary CNS lymphoma (PCNSL) harbors mutations that reinforce B cell receptor (BCR)
signaling. Ibrutinib, a Bruton's tyrosine kinase (BTK) inhibitor, targets BCR signaling and is …

Congenital disorder of oxygen sensing: association of the homozygous Chuvash polycythemia VHL mutation with thrombosis and vascular abnormalities but not …

…, D Okhotin, Y Voloshin, PL Choyke, JA Butman… - Blood, 2004 - ashpublications.org
Adaptation to hypoxia is critical for survival and regulates multiple processes, including
erythropoiesis and vasculogenesis. Chuvash polycythemia is a hypoxia-sensing disorder …

Gadolinium-based MRI characterization of leptomeningeal inflammation in multiple sclerosis

…, MI Reyes-Mantilla, D Maric, PA Calabresi, JA Butman… - Neurology, 2015 - AAN Enterprises
Objective: To determine the frequency and nature of leptomeningeal contrast enhancement
in multiple sclerosis (MS) via in vivo 3-tesla postcontrast T2-weighted, fluid-attenuated …

[HTML][HTML] Iron accumulation in deep cortical layers accounts for MRI signal abnormalities in ALS: correlating 7 tesla MRI and pathology

…, HX Deng, MM Quezado, LE Danielian, JA Butman… - PloS one, 2012 - journals.plos.org
Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized
by cortical and spinal motor neuron dysfunction. Routine magnetic resonance imaging (…